ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,336Medicare Part D Prescriptions Filled, Including Refills

Rank: 327 out of 6969

$758K Total Retail Price of All Prescriptions

Rank: 235 out of 6969

719 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 719 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,500 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 490 446 1 5
LISINOPRIL 454 425 2 2
LOVASTATIN 377 348 3 15
SIMVASTATIN 336 322 4 1
ZOLPIDEM TARTRATE 233 213 5 16
HYDROCHLOROTHIAZIDE 230 220 6 8
ATORVASTATIN CALCIUM 228 214 7 11
ATENOLOL 214 204 8 9
AMLODIPINE BESYLATE 207 202 9 4
HYDROCODONE-ACETAMINOPHEN 200 187 S3 10 3
GABAPENTIN 192 172 11 17
TAMSULOSIN HCL 180 179 12 23
LOSARTAN POTASSIUM 180 175 12 12
ALLOPURINOL 158 156 14 35
CRESTOR 157 153 15 39
METOPROLOL SUCCINATE 145 142 16 22
AZITHROMYCIN 143 120 17 42
WARFARIN SODIUM 130 125 18 20
ALENDRONATE SODIUM 128 117 19 14
GLIMEPIRIDE 125 124 20 44
PANTOPRAZOLE SODIUM 119 105 21 31
DIOVAN 119 107 21 26
POTASSIUM CHLORIDE 116 99 23 30
METFORMIN HCL 116 101 23 7
CIPROFLOXACIN HCL 111 101 25 64
CITALOPRAM HBR 110 102 26 34
OMEPRAZOLE 106 101 27 6
SYNTHROID 104 103 28 94
METFORMIN HCL ER 101 100 29 82
ALPRAZOLAM 99 97 30 172
FUROSEMIDE 98 94 31 10
TRAMADOL HCL 96 92 32 27
METOPROLOL TARTRATE 88 88 33 13
TRIAMTERENE-HCTZ 86 86 34 58
CYMBALTA 80 64 35 72
METHYLPREDNISOLONE 75 70 36 225
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 73 37 28
LOSARTAN-HYDROCHLOROTHIAZIDE 68 64 38 53
CARVEDILOL 68 66 38 25
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 66 40 114
TRAVATAN Z 65 58 41 318
CLOPIDOGREL 64 62 42 48
DOXAZOSIN MESYLATE 64 59 42 74
ADVAIR DISKUS 63 62 44 45
BENICAR 62 61 45 107
LIPITOR 62 55 45 89
ACETAMINOPHEN-CODEINE 61 31 S3 47 73
FLUTICASONE PROPIONATE 60 52 48 24
PAROXETINE HCL 57 57 49 65
DIGOXIN 57 57 49 71
ESTRADIOL 56 46 R 51 124
CLONIDINE HCL 55 55 52 59
FENOFIBRATE 54 54 53 63
AVODART 52 52 54 108
FLUOXETINE HCL 51 41 55 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.